Dare Bioscience Stock Probability of Future Stock Price Finishing Over 2.52
| DARE Stock | USD 2.52 0.02 0.80% |
Dare Bioscience Target Price Odds to finish over 2.52
The tendency of Dare Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.52 | 90 days | 2.52 | about 90.88 |
Based on a normal probability distribution, the odds of Dare Bioscience to move above the current price in 90 days from now is about 90.88 (This Dare Bioscience probability density function shows the probability of Dare Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Dare Bioscience has a beta of -0.23 suggesting as returns on the benchmark increase, returns on holding Dare Bioscience are expected to decrease at a much lower rate. During a bear market, however, Dare Bioscience is likely to outperform the market. Additionally Dare Bioscience has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Dare Bioscience Price Density |
| Price |
Predictive Modules for Dare Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dare Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Dare Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Dare Bioscience is not an exception. The market had few large corrections towards the Dare Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Dare Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Dare Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | -0.23 | |
σ | Overall volatility | 0.24 | |
Ir | Information ratio | -0.07 |
Dare Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Dare Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Dare Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Dare Bioscience generated a negative expected return over the last 90 days | |
| Dare Bioscience has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 9.78 K. Net Loss for the year was (4.05 M) with loss before overhead, payroll, taxes, and interest of (13.22 M). | |
| Dare Bioscience has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Positive Interim Phase 3 Results Highlight Potential of Ovaprene |
Dare Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Dare Stock often depends not only on the future outlook of the current and potential Dare Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dare Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.5 M | |
| Cash And Short Term Investments | 15.7 M |
Dare Bioscience Technical Analysis
Dare Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Dare Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Dare Bioscience. In general, you should focus on analyzing Dare Stock price patterns and their correlations with different microeconomic environments and drivers.
Dare Bioscience Predictive Forecast Models
Dare Bioscience's time-series forecasting models is one of many Dare Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Dare Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Dare Bioscience
Checking the ongoing alerts about Dare Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Dare Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Dare Bioscience generated a negative expected return over the last 90 days | |
| Dare Bioscience has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 9.78 K. Net Loss for the year was (4.05 M) with loss before overhead, payroll, taxes, and interest of (13.22 M). | |
| Dare Bioscience has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Positive Interim Phase 3 Results Highlight Potential of Ovaprene |
Check out Dare Bioscience Backtesting, Dare Bioscience Valuation, Dare Bioscience Correlation, Dare Bioscience Hype Analysis, Dare Bioscience Volatility, Dare Bioscience History as well as Dare Bioscience Performance. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.17) | Revenue Per Share | Quarterly Revenue Growth 1.734 | Return On Assets | Return On Equity |
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.